Author
Junji Suzumiya
Also Known As
Fumiya Wada, J Suzumiya, J. SUZUMIYA, J. Suzumiya, JUNJI SUZUMIYA, Junji SUZUMIYA, Junji Suzumiya, Koji Kato, PESCARMONA, Edoardo
366
Publications
11.1K
Citations
55
H-Index
112
Concepts
All Affiliations
| # | Concept | H-Index | Publications | Citations |
|---|---|---|---|---|
1 | Medicine | 35 | 84 | 4.5K |
2 | Health Sciences | 10 | 11 | 300 |
3 | Allergy | 2 | 2 | 47 |
4 | Allergy Medicine | 1 | 1 | 25 |
5 | Biochemistry | 1 | 1 | 17 |
Junji Suzumiya
×
162
Publications
10.2K
Citations
54
H-Index
| Year | Citations | |
|---|---|---|
2011 | 596 | |
2007 | 454 | |
2003 | 395 | |
2014 | 357 | |
2015 | 302 | |
1985 | 287 | |
2004 | 281 | |
2009 | 257 | |
2004 | 238 | |
Phase I study of dexamethasone, methotrexate, ifosfamide, <scp>l</scp>‐asparaginase, and etoposide (SMILE) chemotherapy for advanced‐stage, relapsed or refractory extranodal natural killer (NK)/T‐cell lymphoma and leukemia Motoko Yamaguchi, Ritsuro Suzuki, Yok‐Lam Kwong, ImmunologyRefractory DiseasesImmunotherapeuticsPharmacotherapyMetronomic Chemotherapy | 2008 | 207 |
Page 1
Page 1